Efficacy and safety of two muscle relaxants cisatracurium and succinylcholine in Electroconvulsive therapy

Phase 3

Recruiting

Conditions: Investigation of using cisatracurium instead of succinylcholine for anesthesia in electroshock therapy in cases that there is a contraindication for succinylcholine.
Other complications of anesthesia
T88.5

Registration Number: IRCT20110425006280N14

Lead Sponsor: Rasht University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 62

Inclusion Criteria

Patients 18 years and older
ASA I,II
Normal body mass index
No criteria for difficult mask ventilation
No contraindication for cisatracurium and succinylcholine

Exclusion Criteria

myasthenia gravis
History of malignant hyperthermia
History of burns
Kidney failure
Guillain-Barré syndrome
Any nerve denervation
Dangerous arrhythmias

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Seizure duration. Timepoint: Momentary monitoring of colonic movements in the organ from the beginning of the seizure. Method of measurement: chronometer.;Time of returning of the effective breaths of the patient. Timepoint: Momentary monitoring from the beginning of the seizure. Method of measurement: chronometer.;Time of recovery. Timepoint: recovery time. Method of measurement: Observation.;Patient discharge from recovery. Timepoint: Momentary monitoring to score 9 or 10. Method of measurement: Aldret score.

Secondary Outcome Measures

Name	Time	Method
Mean arterial blood pressure (MAP). Timepoint: Before injection, 1 minute after seizure and 15 minutes after induction of anesthesia. Method of measurement: Blood pressure measurement.;Heart rate (pulse/ minute). Timepoint: Before injection, 1 minute after seizure and 15 minutes after induction of anesthesia. Method of measurement: Heart rate monitor.